Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2025-12-24 @ 6:37 PM
NCT ID:
NCT00791557
Eligibility Criteria:
Inclusion Criteria:
* Must Be ages 18-75
* Must have both inflammatory bowel disease and moderate to severe pyoderma gangrenosum
* Must never have received Infliximab for the treatment of pyoderma gangrenosum
Exclusion Criteria:
* Have had any previous treatment with monoclonal antibodies other than infliximab used to treat IBD or antibody fragments.
* Have a history of serious infections
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00791557
Study Brief:
Protocol Section:
NCT00791557